Celldex CFO Sam Martin to retire in March 2027
Celldex Therapeutics disclosed that Chief Financial Officer Sam Martin plans to retire effective on or about March 31, 2027, with a search underway for his successor.
Celldex Therapeutics, Inc. said in an 8-K filing that Sam Martin, Senior Vice President and Chief Financial Officer of the company, notified the company on July 10, 2026 of his plans to retire effective on or about March 31, 2027.1
Martin has a long tenure at the company. He joined Celldex in April 2009 and has served as Chief Financial Officer since July 2017.1
To manage the leadership change, the company has initiated a search for a new Chief Financial Officer.1 In the meantime, Martin intends to continue serving as Chief Financial Officer through March 31, 2027 or until an earlier date when his successor begins in that role.1
The filing was signed on July 15, 2026 by Anthony Marucci, President and Chief Executive Officer of Celldex Therapeutics, Inc.1
Written by readthrough’s AI from the linked primary sources and fact-checked against them automatically before publishing. Not investment advice.